The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

BACKGROUND: Breast cancer (BC) is a heterogeneous disease characterised by variant biology and patient outcome. The amino acid transporter, SLC7A5, plays a role in BC although its impact on patient outcome in different BC subtypes remains to be validated. This study aimed to determine whether the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863851/
https://www.ncbi.nlm.nih.gov/pubmed/29566741
http://dx.doi.org/10.1186/s13058-018-0946-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863851/
https://www.ncbi.nlm.nih.gov/pubmed/29566741
http://dx.doi.org/10.1186/s13058-018-0946-6

Ejemplares similares